Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection
- 20 November 2007
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 28 (3), 393-401
- https://doi.org/10.1111/j.1478-3231.2007.01625.x
Abstract
Elevated serum hepatitis B virus (HBV) DNA increases the development of hepatocellular carcinoma (HCC). Rather than instantaneous DNA level, the duration of persistent HBV replication is more important in carcinogenesis. Nevertheless, most investigators evaluated the DNA level at study entry. We assessed the effects of persistently detectable serum HBV DNA on HCC recurrence. We included 230 consecutive patients undergoing curative resection between 2000 and 2006. Patients who had antiviral therapy (at diagnosis or during follow-up), fluctuating DNA (cut-off value: 100,000 copies/ml) or recurrence within 12 months of resection were excluded. Ultimately, 157 were enrolled: 89 (non-viraemia group) had consistently negative DNA (100 000copies/ml). Serum DNA level, biochemical tests, alpha-foetoprotein (AFP) and liver dynamic computed tomography were obtained every 3 months after surgery. There were no significant differences in age, gender, liver function, histology, AFP, tumour stages or follow-up duration between the two groups. During follow-up (median: 35 months), patients in the non-viraemia group had a lower 5-year cumulative recurrence rate (54.7%) than those in the viraemia group (72.9%; P=0.043). In multivariate analysis, sustained viraemia (P=0.041) increased recurrence independently. Persistent viraemia increased recurrence independently after surgery. To prevent long-term recurrences, antiviral therapy should be initiated in those with detectable serum HBV DNA.Keywords
This publication has 30 references indexed in Scilit:
- Radiation-Induced Hepatitis B Virus Reactivation in Liver Mediated by the Bystander Effect from Irradiated Endothelial CellsClinical Cancer Research, 2007
- Chronic hepatitis BHepatology, 2007
- Risk of Recurrence in a Long-term Follow-up After Surgery in 417 Patients With Hepatitis B- or Hepatitis C-Related Hepatocellular CarcinomaAnnals of Surgery, 2006
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- The Actual Five-year Survival Rate of Hepatocellular Carcinoma Patients after Curative ResectionYonsei Medical Journal, 2006
- A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis BGastroenterology, 2005
- Is Hepatic Resection for Large or Multinodular Hepatocellular Carcinoma Justified? Results From a Multi-Institutional DatabaseAnnals of Surgical Oncology, 2005
- Antiviral therapy in HBe-Ag[ndash ]positive hepatitis B with normal aminotransferase levelsHepatology, 2003
- Chemoembolization of Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2002
- Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinomaJournal of the American College of Surgeons, 2000